KRAS and cancer: For instance, KRAS A146T was predicted to be 8.9% of KRAS mutations in PAAD, but is exceedingly rare in this cancer, consistent with the previous demonstration that forced expression of KRAS A146T in mouse pancreas does not induce pancreatic intraepithelial neoplasia4.